Skip to main content
Clinical Trials/NCT05721352
NCT05721352
Recruiting
Phase 1

Arthritis Pain Reduction in Older Adults

Arizona State University1 site in 1 country24 target enrollmentSeptember 15, 2022

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Knee Osteoarthritis
Sponsor
Arizona State University
Enrollment
24
Locations
1
Primary Endpoint
Adherence Measure
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

The goal of this clinical trial is to test using a pain and anxiety reduction phone application in older adults with knee osteoarthritis and chronic pain. The main questions it seeks to answer are:

  1. How acceptable is using a phone app in older adults with knee osteoarthritis and chronic pain to lower pain, pain stress and reduce fear of movement?
  2. What are the effects of combining biofeedback with a virtual reality nature scene and paced breath training to increase heart rate variability on pain and anxiety among older adults with knee osteoarthritis?
  3. What is the role of self-regulation and body awareness in predicting or strengthening the effect of combining virtual reality, heart rate variability biofeedback in older adults with knee osteoarthritis?.

Participants will be asked to:

  1. use a phone application for 7-10 minute sessions twice daily 5 days a week for 8 weeks.
  2. receive relaxation reminders weeks 9 through 12 to see if use continues past the intervention phase.
  3. complete surveys describing pain, physical activity, fear of movement, body awareness and self-regulation, pain stress pre/post the app use.
  4. complete a survey and interview after 8 weeks of phone app use to describe the experience of its use.

Detailed Description

Purpose: This single-group pre-post intervention design, study will explore the feasibility of using a multicomponent phone-based app for 8 weeks to reduce pain, pain stress effects, decreased heart rate variability and fear of movement in 24 older adults with knee osteoarthritis and to examine sustained use and or effects at 4 weeks after intervention period. Aim 1 Evaluate the feasibility (adherence and satisfaction) of a multicomponent phone app combining virtual reality and heart rate variability biofeedback for use in older adults with knee osteoarthritis and chronic pain and gain descriptive evaluations of the experience in exit interviews. Adherence: The adherence benchmark will be 80% of participants will participate at least 5 days per week during the initial 8-week intervention period. Adherence will be examined (not benchmarked) during the 4-week follow-up period. Satisfaction: Exit interviews will demonstrate that 80% of participants practicing with the phone app rate the experience as satisfying or highly satisfying. Aim 2 Evaluate the preliminary effects of multicomponent phone app use (5 days a week for 8 weeks) in older adults with knee osteoarthritis, in relation to pain, pain stress effects, and fear of movement (kinesiophobia), and examine sustained use patterns and effects with only reminders from the app during the 4-week follow-up period. Aim 3: Examine the role of body awareness and self-regulation to moderate (predict) or mediate (strengthen) the effect of a virtual reality nature scene and heart rate variability biofeedback phone application in older adults with knee osteoarthritis.

Registry
clinicaltrials.gov
Start Date
September 15, 2022
End Date
August 15, 2024
Last Updated
2 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Linda Larkey

Professor

Arizona State University

Eligibility Criteria

Inclusion Criteria

  • English speaking adults
  • Diagnosed osteoarthritis of the knee(s)
  • smart phone access
  • Pain scale rating of 4-10 on the numerical pain rating scale (0- 10) \\
  • Pain duration of 3 months or greater
  • Score of 15 or greater on the Tampa Scale of Kinesiophobia (fear of movement) scale
  • Eligibility includes:
  • Willingness to engage in the study for 8 weeks
  • Being available for 1-3 phone calls for data collection at pre- and post-8-week intervention and at 4 weeks post-intervention conclusion
  • Exclusion criteria:

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Adherence Measure

Time Frame: 8 weeks

The adherence benchmark will be 80% of participants will participate at least 5 days per week during the initial 8-week intervention period. Adherence will be examined (not benchmarked) during the 4-week follow-up period

Satisfaction Measure

Time Frame: 8-12 Weeks

Exit interviews will demonstrate that 80% of participants practicing with the phone app rate the experience as satisfying or highly satisfying

Secondary Outcomes

  • Heart Rate(Baseline, 4, 8 and 12 weeks)
  • Brief Fear of Movement scale adapted from the Tampa Scale of Kinesiophobia 11 (TSK-11)(Baseline, 4, 8 and 12 weeks)
  • Patient-reported outcomes measurement information -29 v2.0 system-29 Profile v2.0(Baseline, 4, 8 and 12 weeks)
  • Multidimensional Assessment of Somatic Sense Scale(Baseline, 4, 8 and 12 weeks)
  • Heart rate variability data(Baseline, 4, 8 and 12 weeks)
  • Western Ontario and McMaster Universities Osteoarthritis Severity Index (WOMAC- Stiffness scale(Baseline, 4, 8 and 12 weeks)
  • Customized Technology Adoption Survey(12th Week)
  • Stanford Brief Activity Survey(Baseline, 4, 8 and 12 weeks)
  • Post-Intervention Qualitative Interview(Between 8th and 12th Week)

Study Sites (1)

Loading locations...

Similar Trials